BSE filing, NSE: MAITHANALL. Summary written from the filing by ALFA Finder's alert engine.
Maithan Alloys Ltd: key numbers
- Share price
- ₹789.00
- Market cap
- ₹2,297 Cr
- Revenue (annual)
- ₹2,173 Cr
- Net profit (annual)
- ₹433.6 Cr
- P/E (TTM)
- 7.9×Sector 16.7×
- Promoter holding
- 74.96%+0.00% QoQ
- FII holding
- 0.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Maithan Alloys Ltd
All →Maithan Alloys Board Meeting Date
Maithan Alloys will hold a board meeting on 5 November 2026 to consider unaudited half-yearly results for September 2026. Trading window closed until 7 November 2026.
Maithan Alloys Capital Structure Change
Maithan Alloys acquired 0.04% of Sterlite Technologies via stock exchange for Rs 17.24 Crore. The purchase is an investment, and the company does not intend to acquire control.
- Value
- ₹17.24 Cr
Maithan Alloys Acquisition Worth ₹20.08 Cr
Maithan Alloys Limited acquired 234,000 shares of Sterlite Technologies Limited via the stock exchange. This investment reflects the company's long-term and short-term capital deployment strategy.
- Value
- ₹20.08 Cr
Maithan Alloys Other Announcement
Maithan Alloys invested Rs. 20.08 Crore to acquire a 0.05% stake in Sterlite Technologies Limited via the stock exchange for investment purposes.
- Value
- ₹20.08 Cr
Maithan Alloys Acquisition Worth ₹38.72 Cr
Maithan Alloys acquired 0.09% of Sterlite Technologies (4,39,848 shares) for Rs. 38.72 Crore via stock exchange. The investment carries no control implication.
- Value
- ₹38.72 Cr
Maithan Alloys Business Update
Maithan Alloys acquired 43,984 Sterlite Technologies shares (0.09%) worth Rs.38.72 Crore via stock exchange. The purchase is for investment, with no intent to acquire control.
- Value
- ₹38.72 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.